D.E. Shaw & Co
EUCR

D.E. Shaw & Co’s Eucrates Biomedical Acquisition Corp. Ordinary Shares EUCR Stock Holding History

D.E. Shaw & Co’s Portfolio EUCR Stock Details EUCR Fund Activity
Upgrade to unlock
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
2022
Q3 		$6.68M Hold
2022
Q2 		$6.59M Buy
2022
Q1 		$4.97M Buy
2021
Q4 		$4.67M Buy
2021
Q3 		$1.72M Buy
2021
Q2 		$1.19M Buy